Zafirlukast (accolate): A new treatment for capsular contracture

Aesthetic Surgery Journal

Volumn 22, Issue 4, 2002, Pages 329-336

  Schlesinger, S Larry ^a   Ellenbogen, Richard ^a   Desvigne, Michael N ^a   Svehlak, Steven ^a   Heck, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CEFALEXIN; CEFAZOLIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONTELUKAST; PACLITAXEL; TRASTUZUMAB; ZAFIRLUKAST;

ADULT; ARTICLE; BREAST AUGMENTATION; BREAST RECONSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; FEMALE; HEADACHE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFLAMMATION; INTRADUCTAL CARCINOMA; MASSAGE; MUSCLE CONTRACTURE; NAUSEA;

EID: 0036661036     PISSN: 1090820X     EISSN: None     Source Type: Journal    
DOI: 10.1067/maj.2002.126753     Document Type: Article

References (24)

1. Camirand A, Doucet J, Harris J. Breast augmentation: compression - a very important factor in preventing capsular contracture. Plast Reconstr Surg 1999;104:529-538.
2. Ersek RA. Firestorm fibrosis: the fast fibrotic phenomenon. Ann Plast Surg 1991;20:494-498.
3. Collis N, Coleman D, Foo ITH, Sharpe DT. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants. Plast Reconstr Surg 2000;106:786-791.
4. Collis N, Sharpe DT. Recurrence of subglandular breast implant capsular contracture: anterior versus total capsulectomy. Plast Reconstr Surg 2000;106:792-797.
5. Rohrich RJ, Kenkel JM, Adams WP. Preventing capsular contracture in breast augmentation: in search of the Holy Grail. Plast Reconstr Surg 1999;103:1759-1760.
6. Becker H, Springer R. Prevention of capsular contracture. Plast Reconstr Surg 1999;103:1766-1768.
7. Burkhardt BR. Prevention of capsular contracture. Plast Reconstr Surg 1999;103:1769-1772.
8. Mladick RA. Prevention of capsular contracture. Plast Reconstr Surg 1999;103:1773-1774.
9. Miller AS III, Tarpley SK, Willard, VV, Reynolds, GD, Alteration of fibrous capsule formation by use of immunomodulation. Aesthetic Surg J 1998;18:346-352.
10. Bernstein PR. Chemistry and structure-activity relationships of leukotriene receptor antagonists. Am J Respir Crit Care Med 1998;157:220-226.
11. Calhoun WJ. Summary of clinical trials with zafirlukast. Am J Respir Crit Care Med 1998;157:238-246.
12. 4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. Ann Allergy Asthma Immunol 1998;81:43-49.
13. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-1353.
14. Virchow JC, Prasse A, Naya I, Summerto, L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:578-585.
15. Burkhardt BR. Comparing contracture rates: probability theory and the unilateral contracture. Plast Reconstr Surg 1984;74:527-529.
16. Ko CY, Ahn CY, Ko J, Chopra W, Shaw WW. Capsular synovial metaplasia as a common response to both textured and smooth implants. Plast Reconstr Surg 1996;97:1427-1433.
17. Raso DS, Shlute BA. Immunolocalization of keratan sulfate, chondroitin-4-sulfate, and chondroitin-6-sulfate in periprosthetic breast capsules exhibiting synovial metaplasia. Plast Reconstr Surg 1994;98:78-82.
18. Niessen FB, Spauwen PHM, et al. On the nature of hypotrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435-1458.
19. Tang WW, Van GY, Qi M. Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointestinal nephritis. Kidney Int 1997;51:926-931.
20. Oda D, Gown AM, Vande Berg JS, Stern R. The fibroblast-like nature of myofibroblasts. Exp Mol Pathol 1988;49:316-329.
21. Vistnes LM, Ksander GA. Tissue response to soft silicone prosthesis: capsule formation and other sequelae. In: Rubin LR, editor. Biomaterials in reconstructive surgery. St Louis (MO): Mosby; 1983. p. 516-528.
22. Baker JL Jr, Chandler ML, LeVier RR. Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 1981;68:905-911.
23. Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5 lipoxygenase inhibitors. Am J Respir Crit Care Med 1998;157:233-237.
24. Peters-Golden M. Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med 1998;157:227-232.